tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PTGX is currently covered by 12 analysts with an average price target of $115.92. This is a potential upside of $17.31 (-20.7%) from yesterday's end of day stock price of $146.18.
Protagonist Therapeutics's activity chart (see below) currently has 123 price targets and 132 ratings on display. The stock rating distribution of PTGX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 96.31% with an average time for these price targets to be met of 355.89 days.
Highest price target for PTGX is $151, Lowest price target is $82, average price target is $115.92.
Most recent stock forecast was given by ETZER DAROUT from BARCLAYS on 14-Jul-2026. First documented stock forecast 06-Sep-2016.
Currently out of the existing stock ratings of PTGX, 31 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Dec-2024
$151
$14.36 (10.51%)
$119
Buy Since 09-Sep-2024
$145
$8.36 (6.12%)
$121
Buy Since 05-Nov-2024
$118
$-18.64 (-13.64%)
$86
Buy Since 25-Aug-2022
$137
$0.36 (0.26%)
$112
Buy Since 12-Dec-2024
$116
$-20.64 (-15.11%)
$74
What is PTGX (Protagonist Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?
